Drug Markets/Insulin Lispro

Insulin Lispro

16 NDCs across 2 manufacturers|4 Generic,12 Brand

Insulin Lispro is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $881 million on Insulin Lispro across 3.4 million claims for 1.1 million beneficiaries.

Insulin Lispro is available as 16 NDCs from 2 manufacturers (4 generic, 12 brand), with NADAC prices from $2.40 to $20.31 per ML — the most expensive product costs about 8.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

16

4G / 12B

Manufacturers

2

competing in market

Price Spread

$2.40 – $20.31

per ML

7d Activity

5↑8↓1 flat

avg +0.0% WoW · of 16 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing INSULIN LISPRO

Drug Portfolio

16 NDCs total, 16 shown

Drug ↕Price 7d Change ↕
HUMALOG 200 UNIT/ML KWIKPEN
$20.3101
per ML
-0.01%
ADMELOG 100 UNIT/ML VIAL
$12.5612
per ML
-0.05%
ADMELOG SOLOSTAR 100 UNIT/ML
$12.1092
per ML
+0.03%
INSULIN LISPRO MIX 75-25 KWKPN
$10.2074
per ML
+0.07%
INSULIN LISPRO JR 100 UNIT/ML KWIKPEN
$10.1994
per ML
-0.06%
INSULIN LISPRO 100 UNIT/ML KWIKPEN
$10.1933
per ML
0.00%
HUMALOG 100 UNIT/ML KWIKPEN
$10.1676
per ML
-0.01%
HUMALOG MIX 75-25 KWIKPEN
$10.1667
per ML
-0.03%
HUMALOG JR 100 UNIT/ML KWIKPEN
$10.1583
per ML
-0.01%
HUMALOG MIX 50-50 KWIKPEN
$10.1414
per ML
-0.01%
HUMALOG TEMPO PEN 100 UNIT/ML
$10.1272
per ML
—
HUMALOG 100 UNIT/ML CARTRIDGE
$9.7856
per ML
+0.02%
ADMELOG 100 UNIT/ML VIAL
$9.3938
per ML
+0.01%
HUMALOG MIX 75-25 VIAL
$8.1526
per ML
+0.04%
HUMALOG 100 UNIT/ML VIAL
$6.3574
per ML
-0.02%
INSULIN LISPRO 100 UNIT/ML VL
$2.4026
per ML
0.00%

Frequently Asked Questions

What is Insulin Lispro used to treat?

Insulin Lispro is used to treat type 1 diabetes mellitus, type 2 diabetes mellitus and hyperglycemia, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Insulin Lispro?

In 2024, Medicare Part D spent $881 million on Insulin Lispro across 3.4 million claims for 1.1 million beneficiaries.

How many Insulin Lispro products are on the market?

The Insulin Lispro drug market contains 16 NDCs from 2 manufacturers — 4 generic and 12 brand products.

What is the price range for Insulin Lispro?

NADAC reference prices for Insulin Lispro range from $2.4026 to $20.3101 per ML — the most expensive product costs about 8.5× the cheapest.

Is generic Insulin Lispro cheaper than brand?

The average generic NADAC for Insulin Lispro is $8.2507 per ML, versus $10.7859 for brand-labeled products — generic is about 24% cheaper on average.

Which manufacturers make Insulin Lispro?

2 manufacturers list Insulin Lispro in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (13), Sanofi-Aventis U.S. LLC (3).

How has the price of Insulin Lispro changed recently?

Over the past 7 days, 5 Insulin Lispro NDCs rose and 8 fell, with a market-wide average change of +0.0%.